Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-β-hydroxylase

1. Inhibitory modulation of sympathetic nerve function may have a favourable impact on the progression of congestive heart failure. Nepicastat is a novel inhibitor of dopamine-β-hydroxylase, the enzyme which catalyses the conversion of dopamine to noradrenaline in sympathetic nerves. The in vitro ph...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Stanley, William C, Li, Bin, Bonhaus, Douglas W, Johnson, Lowell G, Lee, Keiho, Porter, Seth, Walker, Keith, Martinez, Greg, Eglen, Richard M, Whiting, Roger L, Hegde, Sharath S
Médium: Artigo
Jazyk:Inglês
Vydáno: 1997
Témata:
Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1564872/
https://ncbi.nlm.nih.gov/pubmed/9283721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0701315
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky